Windlas Biotech Limited
NSE: WINDLAS | Information Technology
Market Fundamentals
Stock Intelligence & News
Windlas Biotech Limited
Manoj Kumar Windlass has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Windlas Biotech Limited
Financial Results/Dividend |Meeting Date: 21-May-2026
Read Full Analysis →Windlas Biotech Limited
WINDLAS BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 21-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. |SUBJECT: Board Meeting Intimation
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about Issue Summary Document (ISD) for Buy-back of Pre Issue Stage through Tender offer |SUBJECT: ISD for Buyback-Tender Offer
Read Full Analysis →Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about Issue Summary Document (ISD) for Buy-back of Pre Issue Stage through Tender offer |SUBJECT: ISD for Buyback-Tender Offer
Read Full Analysis →Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about Copy of Newspaper Publication on submission of copy of Public Announcement pertaining to the Buyback published in newspapers and the Board Resolution |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange that Record date for the purpose of BB is 24-Apr-2026. |SUBJECT: Record Date
Read Full Analysis →Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on April 17, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record date
Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The move covers 2.23% equity and excludes promoters. Shares rose 2% following the announcement, reflecting positive investor sentiment toward the capital return plan.
Read Full Analysis →Windlas Biotech Limited
Windlas Biotech Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Get instant alerts when WINDLAS breaks news
Join investors who track Windlas Biotech Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for WINDLAS?
WINDLAS is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Windlas Biotech Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding WINDLAS to your custom watchlist.